By: Alabama News Center Staff
A fast-growing, Birmingham-based, Black-owned health care startup is partnering with one of the world’s most influential health research and pharmaceutical companies to help boost the participation of African Americans in oncology clinical studies.
Birmingham-based Acclinate is a digital health company focused on improving health equity through predictive analytics technology and community engagement. It recently announced a collaboration with Merck, known as MSD outside the United States and Canada, to help increase Black community participation in Merck’s oncology clinical studies.
“We’re proud to be working with Merck because being a champion for health equity through inclusive research takes strategic orientation and proactiveness. We look forward to seeing how our continued collaboration can positively impact patients,” said Del Smith, Acclinate CEO and co-founder.
The Alabama Weather Blog gladly brings you an excerpt of this article through a partnership with the Alabama NewsCenter. You can see the complete post featuring all the associated images, videos, and links by clicking HERE.
Alabama News Center
All news and articles are copyrighted to the respective authors and/or News Broadcasters. eWeatherNews is an independent Online News Aggregator
Read more from original source here…